(Q24595579)

English

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

scientific article

Statements

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (English)
0 references
Martin Dennis
0 references
Geoff Cohen
0 references
Karen Innes
0 references
Graham Venables
0 references
Stefano Ricci
0 references
Veronica Murray
0 references
Karsten Bruins Slot
0 references
Manuel Correia
0 references
Andre Peeters
0 references
Stephen J Phillips
0 references
Antonio Arauz
0 references
23 June 2012
0 references
0 references
379
0 references
9834
0 references
2352-63
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit